Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 14, 2007

View Archived Issues

Positive preclinical results with a combined hepatitis A and E vaccine

Active end to 2006 for Gilead Sciences

T-2000 improves essential tremor in two small studies

Safety and efficacy of a transdermal Alzheimer's Abeta/CT vaccine shown in mice

Promising preclinical results with Domantis domain antibodies against vaginal candidiasis

Lonafarnib to enter clinic for the treatment of progeria syndromes

SIR-Spheres, bevacizumab + chemotherapy studied for metastatic colorectal cancer

Wyeth welcomes decision to fund pneumococcal vaccine for developing countries

Recent patents cover therapeutic agents for cardiovascular disorders

Novel treatment options for HCV infection reported in recent patents

Recent Bayer and AiCuris patents disclose new antiinfective agents

GSK commends pneumococcal vaccine advance market commitment

PEP-005 Topical studied in phase II trial for superficial BCC

Cytyc to acquire Adeza

Micromet exercises option for Morphotek antibody

Ariad grants commercial license to Argent technology to CellNexus

Ambrx studies next-generation human growth hormone product in phase I/II study

Adolor studies novel delta opioid receptor agonists

Avant and Select Vaccines to develop improved viral vaccines

Fast track designation for BioThrax for anthrax post-exposure prophylaxis

Biovail to use Depomed's AcuForm technology

Findings made available from Diabetes Genetics Initiative

Revisions to U.S. prescribing information for Ketek

Interim data support improvements in inflammatory arthritis with tgAAC94

Ono updates recent developments

Accelerated reviews for maraviroc

Recent Pfizer patent discloses novel therapeutic agents for gastrointestinal disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...